“Embryonic Re-Awakening” in Prostate Cancer; Can We Improve Treatments for Advanced Disease by Targeting Embryonic Pathways?

Speaker: Ralph Buttyan, PhD
Original Date: Tuesday, January 12, 2016

Learn from Dr. Ralph Buttyan, PhD, Professor, Urologic Sciences, University of British Columbia, about:

  • The parts of human embryonic development that become re-activated in prostate cancers that spread or are resistant to treatment
  • How this area of research is leading to novel therapeutic approaches to better control hormone resistant prostate cancer
  • The concept of the “prostate cancer stem cell” 

Dr. Ralph Buttyan's Biography:

Dr. Buttyan received graduate training leading to a PhD in Virology in 1980 at the University of Chicago. An avid bodybuilder at the time, he subsequently joined the Urology Department of Columbia University for Postdoctoral training on the role of androgenic steroids in prostate cancer progression and treatment. He advanced to Full Professor in Pathology and Urology at the site and was Co-Director of the Urologic Malignancies Program of the Herbert Irving Cancer Center. Dr Buttyan moved to Vancouver in 2011 to join the Vancouver Prostate Centre and he is a Professor in Urologic Sciences at the University of British Columbia. He is also the leader of the first Prostate Cancer Canada – Movember Team Grant that brings together investigators from across Canada in an effort to find better treatments for castration resistant prostate cancer. His personal research focuses on the developmental aspects of prostate cancer that drive therapeutic resistance and novel means to overcome the hormone resistant state. 

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive